baber/WOPTO huggingface dataset:
Patent NZ-545682-A (NZ)
Title: Aqueous compositions and method for cleaning gas turbine compressor blades
Inventor: YAN LAIBIN
IPC: C23G1/26
Filed: 2004-08-17
Abstract: Disclosed is a gas turbine cleaning composition comprising a mixture of (a) a glycol alkyl ether compound, (b) an alkoxylated surfactant with an alkyl chain length of from about 3 to 18 carbons and (c) a metal corrosion inhibitor component, wherein the mixture has an alkaline metal content less than about 25 ppm, said metal corrosion inhibitor component is selected from the group consisting of N-methyloleamidoacetic acid, 1,8-octanedicarboxylic acid, (((2-hydroxyethyl) imino) bis-(methylene)) bisphosphonic acid N-oxide, ((tetrahydro-2-hydroxy-4H-1,4,2-oxaphosphorin-4-yl) methyl) phosphonic acid N-oxide, and 5-methyl-1,2,3-benzotriazole, and mixtures thereof with triethanolamine. A method of cleaning a gas turbine compressor and the blades thereof during power generation without significant loss of power is also disclosed, which comprises contacting the surfaces to be cleaned with said gas turbine cleaning composition.
Patent NZ-546464-A (NZ)
Title: Apparatus for handling cells, embryos or oocytes with allows easy access to individual cellular entities
Inventor: DODGSON JOHN ROBERT
IPC: A61B17/435
Filed: 2004-09-10
Abstract: An apparatus for handling cellular entities is disclosed. The apparatus comprises a first substrate (10) having an array of wells (12) open to a first major surface (22) of the first substrate (10), the wells (12) being adapted to hold a cellular entity (14). The apparatus further comprises fluidic channels (26, 28) open to each well (12). The wells (12) are tapered to locate the cellular entity (14) at a given location in each well (12), and the fluidic channels (26, 28) are formed on the major surface of a further substrate (20) adapted and arranged to face the major surface (22) of the first substrate (10), the further substrate (20) being releasably secured to the first substrate (10). This arrangement allows easy access to the individual cellular entities (14).
Patent NZ-550513-A (NZ)
Title: Tetrahydropyridothiophenes
Inventor: PEKARI KLAUS
IPC: A61K31/4365
Filed: 2005-05-25
Abstract: Disclosed are compounds of a formula (I), in which Ra and Rb have the meanings indicated in the description, are novel effective compounds with anti-proliferative and/or apoptosis inducing activity.
Patent NZ-551211-A (NZ)
Title: Compositions with cyclopropenes
Inventor: JACOBSON RICHARD MARTIN
Filed: 2006-11-10
Abstract: Disclosed is a liquid composition that contains one or more cyclopropene and that contains one or more of (AA) one or more plant growth regulator that is not a cyclopropene, or (BB) one or more adjuvant selected from the group consisting of one or more surfactants, one or more alcohols, one or more oils, and mixtures thereof, or (CC) one or more mixture of said (AA) and said (BB). Also provided is a method that includes the step of contacting such compositions to one or more plants or plant parts.
Patent NZ-554628-A (NZ)
Title: Application of tamper evident screw caps to plastics moulded bottles using low pressure top loads to create seal
Inventor: DOWNING DAVID
Filed: 2007-04-18
Abstract: A method of producing a liquid food and beverage product in a bottle made from a polymeric material that is closed by a roll-on tamper evident ("ROTE") closure is disclosed. The as-manufactured bottle has defects in a sealing surface (9) at a top of the bottle of less than 0.1 mm in height or depth to ensure a seal when the method of applying the ROTE closure to the bottle filled with the liquid food and beverage product includes a step of applying a top load of less than 120 kg.
Patent NZ-555071-A (NZ)
Title: Intercalated layered silicate comprising pentaerythritol derivatives as an intercalating agent
Inventor: GRAH MICHAEL D
IPC: C01B33/44
Filed: 2005-12-02
Abstract: Disclosed is an intercalated layered silicate comprising a plurality of silicate layers and an intercalating agent sorbed between the silicate layers to provide an average interlayer spacing of at least twenty Armstrong's, wherein the intercalating agent has the any one of formulas (I)-(V), wherein R1-R8 are defined in the specification. In particular the intercalating agent is an ester or fatty acid ester of pentaerythritol.
Patent NZ-556306-A (NZ)
Title: Method of dispensing drinks
Inventor: VOK PETER GEORGE
Filed: 2007-07-04
Abstract: An apparatus, system and method of dispensing drinks is provided. The system includes an identification device that receives an identification signal from a user, a selection means to select a volume of one or more components to be dispensed to form a drink and verification means to authorise the user and allow the drink to be dispensed at the indicated volume.
Patent NZ-560267-A (NZ)
Title: N-sulphonylpyrroles and their use as histone deacetylase inhibitors
Inventor: MAIER THOMAS
IPC: A61K31/40
Filed: 2006-03-14
Abstract: Disclosed are compounds of a certain formula (I), in which R1 , R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description. These compounds are effective HDAC inhibitors and are suitable for treating diseases responsive or sensitive to inhibition of histone deacetylase activity, as such these compounds are used in the manufacture of pharmaceutical compositions for treating, preventing or ameliorating benign and/or malignant neoplasia, such as e.g. cancer. These compounds may also be suitable for treating other diseases, such as e.g. arthropathies and osteopathological conditions, autoimmune diseases including transplant rejection, acute and chronic inflammatory diseases, hyperproliferative diseases or neuropathological disorders.
Patent NZ-562240-A (NZ)
Title: Grouped exposed metal heaters for treating hydrocarbon formation including groups of triads of three-phase heaters
Inventor: COIT WILLIAM GEORGE
IPC: E21B36/04
Filed: 2006-04-21
Abstract: Disclosed is a system for treating a hydrocarbon containing formation in order to produce a fuel. The system includes two or more groups (270) of elongated heaters. A group includes a triad of three-phase heaters (A, B, C) placed in openings in the formation. The heaters in the group comprise at least in part an exposed metal heater and are electrically coupled (274) below the surface of the formation. The openings are at least partially uncased wellbores in a hydrocarbon layer of the formation. The groups are electrically configured and physically arranged such that current flow through the formation between at least two groups is inhibited, by coupling each triad of heaters to its own isolated three-phase transformer. This results in the triads being electrically insulated from each other. The heaters are configured to provide heat to the formation
Patent NZ-562873-A (NZ)
Title: Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3 -receptor ligands
Inventor: BERTRAND ISABELLE
IPC: A61K31/381
Filed: 2006-04-25
Abstract: Provided is a compound of formula (I), with R1 and R2 taken together with the nitrogen atom to which they are attached, form a mono or bicyclic saturated nitrogen-containing ring; R is chosen from the groups selected within: a) a ring chosen from pyridyl, optionally substituted with one or more of halogen atom, C1-C4 alkyl, O-C1-C4 alkyl, OH, monocyclic saturated or partially saturated heterocycloalkyl, or cycloalkyl, each optionally substituted with one or more of halogen atom, C1-C4 alkyl, O-C1-C4 alkyl, OH, NR3R4 and/or where the heterocycloalkyl or pyridyl comprises a N-atom within the ring, the N atom may be in the form of N-Oxyde (N+-O-), or 15 b) chosen from mono or bicyclic aryl optionally substituted with one or more of halogen atom, C1-C4 alkyl, O-C1-C4 alkyl, OH, NR3R4, -C2-C4 alkenyl or -C2-C4 alkynyl, where alkyl, alkenyl or alkynyl is optionally substituted with a heterocycle; wherein R3, R4 represent independently hydrogen, a straight or branched C1- C4 alkyl or an aryl group or taken together with the nitrogen atom to which they are attached form a saturated or partially unsaturated monocyclic or bicyclic heterocycle or heteroaryl optionally comprising one or more further heteroatoms and/or optionally substituted with one or more of halogen atom, C1-C4 alkyl, O-C1-C4 alkyl, OH. Further provided are various salts and polymorphic crystalline structures and their isomers, racemates
Patent NZ-569052-A (NZ)
Title: Lyophilization process and products obtained thereby
Inventor: PALEPU Nageswara
IPC: A61K9/14
Filed: 2006-10-13
Abstract: Disclosed is a method of lyophilizing a material comprising: (a) dissolving said material in a solvent for said material to form a solution; or making a slurry of the material and adjusting the pH to dissolve the drug to form a solution (b) adding a non-solvent for said material to said solution, which non-solvent is miscible with said solvent to force said material at least partially out of said solution, and wherein said non-solvent is volatilizable under freeze-drying conditions; (c) freezing the result of step (b) to yield a frozen result, said frozen result comprising a frozen portion and (d) vacuum drying the result of step (c) to yield a lyophilizate. Also disclosed is a compound or composition produced by said method and the use of said compound to administer a medicament to the eye, oral mucosa, rectum, vaginal, uterine, urethral, and urinary bladder tissues.
Patent NZ-570398-A (NZ)
Title: Intervertebral disc replacement which provides multi-axial non-impact motion attenuation
Inventor: TAUBER MICHAEL
IPC: A61F2/44
Filed: 2007-02-22
Abstract: Disclosed is an apparatus for replacing at least a portion of an intervertebral disc in a spinal column between endplates of a first vertebral body and a second vertebral body of a spinal column, the apparatus comprises a first member with a first vertebral contact surface for engagement with the first vertebral body endplate, and a first articulation surface. The apparatus also includes a second member with a second vertebral contact surface for engagement with the second vertebral body endplate, and a second articulation surface. An intervertebral spacing is defined as the axial component of a line extending between a centroid of the first vertebral contact surface and a centroid of the second vertebral contact surface. The first articulation surface and the second articulation surface form at least part of an articulation arrangement configured such that, when loaded with compressive axial force the first and second vertebral contact surfaces are supported against the compressive force to ensure a predefined minimum intervertebral spacing. The second member is displaceable relative to the first member in motion corresponding to axial rotation, anterior-flexion and posterior extension, and lateral bending, each of the motions having a corresponding range of motion. The intervertebral spacing increases as a smooth function of angular displacement from a neutral position over at least part of the range of motion in each direction for each of the axial rotation, anterior-flexion and posterior extension and lateral flexion, thereby providing non-impact motion attenuation.
Patent NZ-575838-A (NZ)
Title: Composition comprising loratadine and phenylephrine and its use in a method for treatment of patients with upper respiratory mucosal congestion
Inventor: ATKINSON HARTLEY CAMPBELL
IPC: A61K31/135
Filed: 2005-06-17
Abstract: Disclosed is a pharmaceutical composition including loratadine or a pharmaceutically acceptable form thereof, and phenylephrine or a pharmaceutically acceptable form thereof, for treating upper respiratory/mucosal congestion and the composition is for administering four times a day.
Patent NZ-576832-A (NZ)
Title: Travelling water permeable screen with linear flghts and compressible boot side seal in a u-shaped profile
Inventor: WUNSCH PHILIP J
IPC: B01D33/056
Filed: 2007-10-03
Abstract: A travelling water screen system (12) comprising a vertically travelling water screen (14) having an outer screen surface (26) and rows of flights (24) extending outwardly from the outer screen surface (26) and laterally across the width of the water screen between the flight side edges, the travelling water screen forming a continuous loop. The screen system is supported by a structure confining the water sieve in a trough (32) forming a trough with a side seal (36) at each end, having wear surfaces of a resiliently compressible material toward the side of the support structure by contact with the passing flight side edges. The seals are made from foam, while the screen is made from nylon.
Patent NZ-583787-A (NZ)
Title: Human gm-csf antigen binding proteins
Inventor: KIRCHNER JACQUELINE A
IPC: A61K39/395
Filed: 2008-09-18
Abstract: An antibody that binds GM-CSF (granulocyte/macrophage-colony stimulating factor) that comprises the heavy chain CDRs SEQ ID NOs: 22, 23 and 24, and the light chain CDRs SEQ ID NOs: 16, 17 and 18. The antibody can be used to treat multiple sclerosis, rheumatoid arthritis, asthma, psoriasis, atopic dermatitis and sarcoidosis.
Patent NZ-590793-A (NZ)
Title: Therapeutic agent for migraine
Inventor: IKEDA JUNICHI
IPC: A61K31/52
Filed: 2009-07-23
Abstract: Disclosed herein is the use of 5-furan-2-yl-thiazo-2-yl derivatives of formula II, in particular the compounds as represented by the compounds of formula IIA-IID, or a pharmaceutically acceptable salt thereof for the manufacture of a therapeutic and/or preventive agent for migraine.
Patent NZ-592698-A (NZ)
Title: An unforgeable and unabusable portable electronic parking permit tag for vehicles transporting disabled persons and a parking permit method using the electronic parking permit tag
Inventor: LIDROR OFER
IPC: G07B15/02
Filed: 2009-11-09
Abstract: An unforgeable and unabusable portable electronic parking permit tag for vehicles transporting disabled persons and a parking permit method for preventing forging and abuse of parking tags for vehicles are disclosed. The electronic parking permit tag (10) for vehicles transporting disabled persons comprises: a) a casing placeable in a vehicle (11) so that a universal disabled person symbol (15) and a parking authorization provided with the casing are visible from around the vehicle; b) a memory module for storing data regarding the person(s) allowed to activate the tag, in which the stored data represents at least a portion of personal biometric information of each of the person(s) and includes data burned into the memory module; c) a biometric identification module (22) for obtaining biometric data of the person trying to activate the tag; d) at least one display unit (17) for indicating the status of the tag, whether activated or deactivated; e) a processing unit for comparing the obtained biometric data with the stored data and for triggering the tag status to an activated status if the obtained biometric data and the stored data match; f) means for deactivating the tag when the vehicle is not in a parking position anymore or when the tag is moved after being activated; g) a transmitter for periodically transmitting secured data related to the name and authorization number of the disabled person who activated the tag, to be received and verified by a parking authority; and h) means for powering the tag.
Patent NZ-593427-A (NZ)
Title: Dosage regimen of an s1p receptor agonist
Inventor: LEGANGNEUX ERIC
IPC: A61K31/192
Filed: 2009-12-21
Abstract: 593427 Disclosed is the use of an S1P receptor modulator or agonist compound 1-{ 4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl} -azetidine-3-carboxylic acid (Compound A), a salt, a pharmacologically acceptable salt thereof or prodrug thereof, wherein said prodrug is defined as a compound that is transformed to the compound of formula la by hydrolysis, in the manufacture of a medicament for the treatment of an autoimmune condition in a patient, whereby the medicament is adapted to provide said S1P receptor modulator or agonist at a dosage lower than the standard daily dosage of said S1P receptor modulator or agonist during an initial period of treatment and then at an increased dosage, up to the standard daily dosage of said S1P receptor agonist.
Patent NZ-595207-A (NZ)
Title: Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
Inventor: BRUGGEMEIER ULF
IPC: A61K31/4196
Filed: 2010-03-12
Abstract: 595207 This disclosure relates to a family of compounds with a 2-acetamido-5-aryl-1,2,4-triazolone core as seen in (I) and their corresponding salts. A is a C1 – C2 linker; R1 is alkyl, alkenyl or cyclopropyl; R2 is phenyl; R3 is a heteroatom containing functional group; R4 is a substituted phenyl and R5 is methyl or hydrogen. The compounds are useful in the treatment of cardiovascular and other diseases, including chronic cardiac insufficiency, hypovolemic and euvolemic hypernatremia, liver cirrhosis, ascites, oedemas and the syndrome of inadequate ADH secretion (SIADH). The disclosure also relates to the preparation of these compounds and their use in medicaments for the above mentioned conditions.
Patent NZ-597400-A (NZ)
Title: Methods and Materials Using Signaling Probes
Inventor: SHEKDAR KAMBIZ
IPC: C12N5/00
Filed: 2005-02-17
Abstract: 597400 METHODS AND MATERIALS USING SIGNALING PROBES Provided is a transplantable composition comprising a plurality of isolated living cells, wherein at least a subset of the cells expresses an RNA that is not expressed by another subset of the cells, and wherein the plurality of cells is obtainable by a method comprising the steps of: (a) introducing into cells a plurality of DNAs encoding a plurality of different RNAs, wherein each DNA further encodes a tag sequence, wherein at least a subset of the plurality of DNAs encodes the same tag sequence; (b) exposing said cells to a same signalling probe that produces a detectable signal upon hybridization to said same tag sequence; and (c) isolating said cells that produce the signal, wherein the different RNAs are expressed at a comparable level in the plurality, and wherein said tag sequence is not translated into a protein, or if it is translated, it does not aid in the subsequent detection of the protein encoded by the RNA
Patent NZ-598835-A (NZ)
Title: Method of contaminant prediction
Inventor: MCLAUGHLIN MICHAEL JOHN
IPC: G01N21/35
Filed: 2010-09-24
Abstract: 598835 Disclosed herein is a method of selectively predicting hydrocarbon concentration in a sample of unknown hydrocarbon concentration (the unknown sample), said method comprising the steps of: (i) separately subjecting two or more samples of known hydrocarbon concentration to infrared (IR) radiation, at least two of the samples having different hydrocarbon concentrations; (ii) separately detecting an IR signal from the samples of known hydrocarbon concentration; (iii) analysing the IR signals using a multivariate chemometric technique to produce a training data set; (iv) generating a predictive model for hydrocarbon concentration based on the training data set; (v) subjecting the unknown sample to infrared (IR) radiation; (vi) detecting an IR signal from the unknown sample; (vii)applying the predictive model to the IR signal from the unknown sample; and thereafter (viii) selectively predicting hydrocarbon concentration in the unknown sample. Also disclosed are a method of generating a model to selectively predict hydrocarbon concentration in a sample of unknown concentration, and also a software program for carrying out the associated calculations.
Patent NZ-599166-A (NZ)
Title: Wrap-around label, labelstock and labelling process
Inventor: BENTLEY GREGORY
IPC: G09F3/10
Filed: 2010-09-15
Abstract: The specification relates a label formed from label stock. The label stock has a continuous web of material having a machine direction (MD) and a transverse direction (TD). The label includes a severed portion of the continuous web of material. The severed portion has a leading edge in the TD, a trailing edge in the TD, a first lateral edge in the MD, a second lateral edge in the MD, an A side; and a B side. The label has a MD fold about the severed portion of the continuous web of material. The MD fold has a first A to A fold and a second A to A fold. The label has an adhesive TD strip disposed on a back of the label across the leading edge and the trailing edge. The severed portion of the continuous web of material has printed or other information inside the MD fold. The printed or other information inside the MD fold is hidden until the MD fold is unfolded.
Patent NZ-603432-A (NZ)
Title: Method for the treatment of a liquid, in particular a mineral oil
Inventor: NUERK RUEDIGER UWE
IPC: C10G15/08
Filed: 2011-04-14
Abstract: A method and device (1) for the treatment to increase the portion of low-boiling fractions in a mineral oil is disclosed. The treatment comprises subjecting the oil (2) to pressure waves of a first frequency in a pressure wave generator (5). A portion of the oil is recirculated through pipes (6) from an exit (7) of the pressure wave generator to return to the pressure generator (8) which forms a resonant system. The system is exited to a resonant frequency which is different to the first frequency. The pressure in the recirculation pipe (6) can be adjusted by a throttle valve (9) to tune the system resonance to the second frequency. The treated oil then exits the device into tank (3).
Patent NZ-612094-A (NZ)
Title: Native (telopeptide) placental collagen compositions
Inventor: BHATIA MOHIT
IPC: C12N5/0735
Filed: 2007-10-09
Abstract: Disclosed is a composition comprising placental extracellular matrix (ECM), wherein said ECM comprises at least 80% collagen by dry weight and wherein said composition comprises at least 10% elastin by dry weight, wherein said composition further comprises a plurality of stem cells that does not comprise human totipotent cells, and wherein said collagen comprises between 74-92% Type I collagen and between 4-6% Type III collagen.
Patent NZ-614453-A (NZ)
Title: Transport and presentation box
Inventor: ORGELDINGER WOLFGANG
IPC: B65D6/16
Filed: 2009-11-17
Abstract: A box such as a bottle crate is disclosed comprising a floor and at least two pairs of respectively opposing side walls (16a, 16b, 14a, 14b). A first of the side walls (16b) extends from the floor by a removal height that is lower than the height of one or several of the other side walls in order to allow access to and removal of products contained in the box. The box further includes a moveable side wall area (23) arranged on the first wall so that it can be folded down in an overlapping manner.
Patent NZ-618537-A (NZ)
Title: Mitochondrial aldehyde dehydrogenase (aldh-2) inhibitors
Inventor: CANNIZZARO CARINA E
IPC: C07F9/58
Filed: 2012-06-29
Abstract: Provided are N-(4-(2-oxo-1,2-dihydropyridin-4-yl)benzyl)benzamide compounds of the general formula (I), wherein the variables are as defined in the specification. Examples of the compounds include 2,6-dichloro-4-(2-methoxyethoxy)-N-(4-(2-oxo-1,2-dihydropyridin-4-yl)benzyl)benzamide and 2,6-dichloro-N-(4-(5-fluoro-2-oxo-l,2-dihydropyridin-4-yl)benzyl)benzamide. The compounds are aldehyde dehydrogenase (ALDH-2) inhibitors. The compounds may be useful for treating dependence upon substances of addiction, such as cocaine, morphine, amphetamines, nicotine, and/or alcohol.
Patent NZ-620217-A (NZ)
Title: Collector of liquid
Inventor: BUREAU MAXIME PIERRICK FRANÇOIS
IPC: A61M1/00
Filed: 2012-07-24
Abstract: A multi-layered liquid collection structure for collecting fluids spilled, for example, during surgery. The structure comprises a first bottom layer (1) and a third layer (3) each with a set of openings for receiving liquid. A second layer (2) between the first (1) and third (3) layers comprises a vacuum tube (7) and a material which facilitates the generation and maintenance of a uniform vacuum between the layers for liquid collection. A fourth layer (4) is located above the third layer (3) and absorbs liquid by capillary action. Liquid is distributed along the absorbent fourth layer (4) and is evacuated via the holes in the third layer (3) and liquid can also be removed through the holes in the first layer (1).